Coronary Atherosclerosis: Pathophysiologic Basis for Diagnosis and Management

Area of Science:

• Cardiovascular Medicine
• Pathophysiology
• Clinical Research

Background:

• Coronary atherosclerosis is a chronic, progressive condition with diverse clinical outcomes, including stable angina, acute coronary syndrome (ACS), heart failure (HF), and sudden cardiac death (SCD).
• Both genetic predispositions and environmental exposures play significant roles in the initiation and advancement of coronary atherosclerosis.
• Understanding the pathophysiologic underpinnings is crucial for effective clinical strategies.

Purpose of the Study:

• To review current knowledge on the diagnosis and management of coronary atherosclerosis, integrating pathophysiologic insights.
• To bridge the gap between population-level data from epidemiological studies and randomized clinical trials (RCTs) and individual patient care.
• To highlight the challenges and strategies for applying evidence-based medicine in the personalized treatment of coronary atherosclerosis.

Main Methods:

• Literature review synthesizing current understanding of coronary atherosclerosis.
• Discussion of pathophysiologic mechanisms driving disease development and progression.
• Analysis of epidemiological data and RCT findings for clinical application.

Main Results:

• Coronary atherosclerosis presents a spectrum of clinical manifestations, from asymptomatic disease to life-threatening events.
• Pathophysiology provides a framework for understanding disease progression and informing therapeutic targets.
• Integrating population data with individual patient factors is key for optimal management.

Conclusions:

• Effective management of coronary atherosclerosis requires a deep understanding of its pathophysiology and clinical presentation.
• Translating epidemiological and trial data into personalized patient care remains a significant clinical challenge.
• Future efforts should focus on enhancing clinicians' ability to apply evidence-based knowledge to individual patient needs in managing coronary atherosclerosis.